Assessing Inherited Markers of Metabolic Syndrome in the Young (AIMMY)
Sponsor: East Carolina University
Listed as NCT00966407, this observational or N/A phase trial focuses on Diabetes Mellitus, Type 2 and Metabolic Syndrome and remains completed. Sponsored by East Carolina University, it has been updated 13 times since 2007, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Mar 2020 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Mar 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Feb 2017 — Aug 2017 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- East Carolina University
- Eric Hoffman
- Howard University
- National Institute on Minority Health and Health Disparities (NIMHD)
- University of Massachusetts, Worcester
For direct contact, visit the study record on ClinicalTrials.gov .